Close Menu

NEW YORK – Chinese diagnostic company WuXi Diagnostics announced on Tuesday that it has closed a $150 million Series B financing round.

The round was led by new investors including Thermo Fisher Scientific, Shiyu Capital, ABC International, Sunland Capital, and CCBI Tech Venture, Existing investor YF Capital, along with CEC Capital, were the exclusive financial advisor.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.